These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1326 related items for PubMed ID: 19231106

  • 1. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1522-8. PubMed ID: 19231106
    [Abstract] [Full Text] [Related]

  • 2. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 3. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 4. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 01; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
    Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B.
    Gynecol Oncol; 1994 Mar 01; 52(3):326-31. PubMed ID: 8157190
    [Abstract] [Full Text] [Related]

  • 6. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM, Gorla GR, Garg M, Anderson PS, Fields AL, Runowicz CD, Goldberg GL, Vikram B.
    Cancer; 2003 Apr 01; 97(7):1781-8. PubMed ID: 12655536
    [Abstract] [Full Text] [Related]

  • 7. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K, Gallop-Evans E, Hanna L, Adams M.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):140-6. PubMed ID: 18922646
    [Abstract] [Full Text] [Related]

  • 8. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.
    N Engl J Med; 1999 Apr 15; 340(15):1137-43. PubMed ID: 10202164
    [Abstract] [Full Text] [Related]

  • 9. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY, Li LY, Shu KY, Pan M, Li HP, Luo B.
    Ai Zheng; 2008 Sep 15; 27(9):942-6. PubMed ID: 18799032
    [Abstract] [Full Text] [Related]

  • 10. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 15; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 11. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2007 Jan 15; 104(1):95-9. PubMed ID: 16996117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 15; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 15; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 18. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study.
    Chatani M, Matayoshi Y, Masaki N, Narumi Y, Teshima T, Inoue T.
    Strahlenther Onkol; 1995 Nov 01; 171(11):655-60. PubMed ID: 7502230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.